Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
New York State Pension commits $3bn to private equity and alternatives
The New York State Common Retirement Fund, one of the largest public pension funds in the US, allocated over $3bn in November 2024. More than $2.7bn went to private equity. Over the past six months, NYSCRF has committed a total of $5.4bn to private equity. Among the...
Generali and Natixis form €1.9tn asset management joint venture
Generali and Groupe BPCE, parent company of Natixis Investment Managers, have agreed to merge their asset management operations, forming a joint venture managing €1.9tn ($1.98tn) in AUM. This partnership positions the new entity as the ninth-largest asset manager...
Thoma Bravo closes $3.6bn Credit Fund III to support enterprise software companies
Thoma Bravo announced the close of its Credit Fund III, securing $3.6bn in total available capital, including anticipated leverage. This milestone marks the firm’s largest credit fund to date, reflecting its leadership in the private credit market for enterprise...